On July 15, 2020, the Substance Abuse and Mental Health Services Administration (SAMHSA) made substantial changes to the permitted uses and disclosures of substance use disorder (SUD) records for programs covered by 42 C.F.R. Part 2. The stated intent of
Health Law Insider
Developments and trends in the health care industry
Health Law Insider, published by Stoel Rives LLP, focuses on legal issues affecting healthcare providers, organizations, and businesses. The blog covers topics such as regulatory compliance for healthcare entities, including the Corporate Practice of Medicine doctrine and state-specific ownership restrictions. It addresses privacy and data protection concerns, including updates on privacy policies, consent management, and digital health technologies. The blog also discusses employment and credentialing risks in healthcare settings, telemedicine and digital primary care legal challenges, and hospital staffing regulations. Its content is aimed at helping healthcare professionals navigate evolving legal and regulatory landscapes to mitigate risks and ensure compliance.
Latest from Health Law Insider - Page 3
Non-Urgent and Elective Procedures Update: Oregon and Washington Ease Prohibitions
In a previous Health Law Insider blog post, Stoel Rives’ health care team discussed the prohibition on elective procedures promulgated by Oregon and Washington in an effort to conserve the states’ supply of Personal Protective Equipment (“PPE”) and manage…
Important Deadlines Delayed for Health and Welfare Plans due to COVID-19 Emergency: Impacts for Employer Plan Sponsors, Administrators, and Insurers
The Employee Benefits Security Administration (EBSA) of the Department of Labor (DOL) and the Department of Treasury and Internal Revenue Service (IRS) issued a notification of relief, effective immediately, that extends certain critical deadlines in health, disability, and other…
COVID-19 Update: FCC Accepting Applications for Its $200M Telehealth Program; Red Light Rule Waived
In a previous client alert, Stoel Rives’ health care team provided responses to certain frequently asked questions regarding the Federal Communications Commission’s (“FCC”) COVID-19 Telehealth Program (“Program”). At the time of that earlier client alert, FCC was awaiting the…
COVID 19 Update: Minnesota’s Ban on Elective Procedures, Providers May Be Compelled to Donate or Sell Medical Equipment
In a previous blog post, Stoel Rives’ health care team discussed orders issued by Washington and Oregon that banned elective procedures in an effort to preserve the states’ supply of certain medical equipment. Minnesota has issued similar orders to…
HHS Distributes $30 Billion from CARES Act Public Health Emergency Funds
On April 10, 2020, HHS announced the distribution of the first tranche of $30 Billion from the Provider Relief Funds authorized and appropriated under the CARES Act and deposited within HHS’s Public Health and Social Services Emergency Fund. The funds…
FCC Releases $200M COVID-19 Telehealth Program Guidance: Your Questions Answered
On April 2, 2020, the Federal Communications Commission (“FCC”) released its Report and Order 20-44 outlining how it plans to distribute $200 million appropriated to it by the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”). The COVID-19…
Desperate Times, Desperate Measures: Elective Medical Procedures Banned, PPEs at Risk of Confiscation
In an effort to conserve the state’s medical supplies and equipment, specifically personal protective equipment (PPE), Washington and Oregon (among other states) have banned non-urgent, elective procedures.[1] A move that the states hope will help ensure adequate supply of…
New Oregon Telehealth Rules to Assist Providers with COVID-19 Pandemic Efforts (Updated March 31, 2020)
Several updates have made by the Oregon Health Authority (“OHA”) and the Health Evidence Review Commission (“HERC”) since this alert was first posted. The following is updated as of March 31, 2020.
On March 16, 2020, the Oregon Health Authority…
COVID-19 Leads to Liberalization of e-Prescribing of Controlled Substances, May Presage Permanent Rulemaking
In light of the COVID-19 pandemic, the Drug Enforcement Agency (“DEA”) recently issued guidance permitting the use of telemedicine to prescribe controlled substances (schedule II to V) for the duration of the public health emergency declared by the Secretary of…